MB MAINLINE BIOSCIENCES

Serial Number 97683356
616

Registration Progress

Application Filed
Nov 18, 2022
Under Examination
Mar 11, 2025
Approved for Publication
Jan 14, 2025
Published for Opposition
Jan 14, 2025
Registered

Trademark Image

MB MAINLINE BIOSCIENCES

Basic Information

Serial Number
97683356
Filing Date
November 18, 2022
Published for Opposition
January 14, 2025
Drawing Code
5

Status Summary

Current Status
Active
Status Code
616
Status Date
Oct 13, 2025
Application
Pending
Classes
005 042

Rights Holder

Mainline Biosciences (Shanghai) Co., Ltd.

16
Address
1666 Xinyang Road, Building 2
Lingang, Shanghai 201413
CN

Ownership History

Mainline Biosciences (Shanghai) Co., Ltd.

Original Applicant
16
Lingang, Shanghai CN

Mainline Biosciences (Shanghai) Co., Ltd.

Owner at Publication
16
Lingang, Shanghai CN

Legal Representation

Attorney
Don D. Cha

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Oct 13, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 13, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 13, 2025 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Oct 13, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 13, 2025 PETG O PETITION TO REVIVE-GRANTED Loading...
Oct 13, 2025 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Oct 13, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Mar 11, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 14, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 14, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 8, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2024 ALIE A ASSIGNED TO LIE Loading...
Oct 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 17, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 17, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jul 17, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Jul 17, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Apr 11, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 11, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jan 11, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 11, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 11, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 1, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 1, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 1, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 1, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
Class 042
Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals

Additional Information

Design Mark
The mark consists of a stylized blue "M" to the left of a stylized light blue "B" above the stylized blue wording "MAINLINE BIOSCIENCE".
Color Claim
The color(s) blue and light blue is/are claimed as a feature of the mark.
Other
The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018
Other
The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018
Other
The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018
Other
The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"